Expression of endothelin peptides and mRNA in the human heart

Clinical Science

Volumn 90, Issue 1, 1996, Pages 37-46

  Plumpton, C ^a   Ashby, M J ^a   Kuc, R E ^a   O'Reilly, G ^a   Davenport, A P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Big endothelin; Endothelin; High performance liquid chromatography; Human endocardial endothelial cells; Immunocytochemistry; Radioimmunoassay; Reverse transcriptase polymerase chain reaction

Indexed keywords

CARDIOTONIC AGENT; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; MESSENGER RNA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR FUNCTION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CROSS REACTION; CYTOPLASM; ENDOTHELIUM CELL; GENE AMPLIFICATION; GENE EXPRESSION; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030065517     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0900037     Document Type: Article

References (45)

1. Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989; 86: 2863-7.
2. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding in endothelin receptor. Nature (London) 1990; 348: 730-2.
3. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (London) 1990; 348: 732-5.
4. Howard PG, Plumpton C, Davenport AP. Anatomical localisation and pharmacological activity of mature endothelins and their precursors in human vascular tissue. Hypertension 1992; 10: 1379-86.
5. A receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol 1995; 115: 191-7.
6. Godfraind T. Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol 1993; 110: 1201-5.
7. Opgaard OS, Adner M, Gulbenkian S, Edvinsson L. Localisation of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J Cardiovasc Pharmacol 1994; 23: 576-83.
8. Davenport AP, Maguire JJ. Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans? Trends Pharmacol Sci 1994; 15: 9-11.
9. Franco-Cereceda A. Endothelin- and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro. Br J Pharmacol 1989; 97: 968-72.
10. 125I]endothelin-1 in humans, pigs and rats: functional relevance in man. J Cardiovasc Pharmacol 1989; 13: S166-70.
11. 2+ and contractility in single ventricular myocytes from the ferret and human. Eur J Pharmacol 1992; 214: 293-6.
12. Moravec CS, Reynolds EE, Stewart RW, Bond M. Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun 1989; 159: 14-18.
13. Poli E, Barboso G, Casoli C, Starcich R, Bertaccini G. Positive inotropic effect of endothelin-2 on human atrium preparations in vitro. Cardioscience 1991; 2: 99-104.
14. Molenaar P, O'Reilly G, Sharkey A, et al. Characterisation and localisation of endothelin receptor sub-types in the human atrioventricular conducting system and myocardium. Circ Res 1993; 72: 526-38.
15. Wharton J, Rutherford RAD, Gordon L, et al. Localization of endothelin binding sites and endothelin-like immunoreactivity in human fetal heart. J Cardiovasc Pharmacol 1991; 17: S378-84.
16. Plumpton C, Champeney R, Ashby MJ, Kuc RE, Davenport AP. Characterisation of endothelin isoforms in human heart: endothelin 2 demonstrated. J Cardiovasc Pharmacol 1993; 22: S26-8.
17. Brutsaert DL, Andries LJ. The endocardial endothelium. Am J Physiol 1992; 263: H985-1002.
18. Smith JA, Shah AM, Lewis MJ. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol 1991; 439: 1-14.
19. Marciniak SJ, Plumpton C, Barker PJ, Huskisson NS, Davenport AP. Localization of immunoreactive endothelin and proendothelin in the human lung. Pulmon Pharmacol 1992; 5: 175-82.
20. O'Reilly G, Charnock-Jones DS, Cameron IT, Smith SK, Davenport AP. Endothelin-2 mRNA splice variants detected by RT-PCR in cultured human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 1993; 22: S18-21.
21. O'Reilly G, Charnock-Jones DS, Morrison JJ, Cameron IT, Davenport AP, Smith SK. Alternatively spliced mRNAs for human endothelin-2 and their tissue distribution. Biochem Biophys Res Commun 1993; 193: 834-40.
22. O'Reilly G, Charnock-Jones DS, Davenport AP, Cameron IT, Smith SK. Presence of mRNA for endothelin-1, endothelin-2 and endothelin-3 in human endometrium, and a change in the ratio of ET-A and ET-B receptor subtype across the menstrual cycle. J Clin Endocrinol Metab 1992; 75: 1545-9.
23. Kimura S, Kasuya Y, Sawamura T, et al. Structure-activity relationships of endothelin: importance of the C-terminal moiety. Biochem Biophys Res Commun 1988; 156: 1182-6.
24. Plumpton C, Haynes WG, Webb DJ, Davenport AP. Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm. Br J Pharmacol 1995; 116: 1821-8.
25. Naruse M, Kawana M, Hifumi S, et al. Plasma immunoreactive endothelin, but not thrombomodulin, is increased in patients with essential hypertension and ischaemic heart disease. J Cardiovasc Pharmacol 1991; 17: S471-4.
26. Nunez DJR, Brown MJ, Davenport AP, Neylon CB, Schofield JP, Wyse RK. Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest 1990; 85: 1537-41.
27. Hemsen A, Franco-Cereceda A, Matran R, Rudehill A, Lundberg JM. Occurence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue. Eur J Pharmacol 1990; 191: 319-28.
28. Moody CJ, Dashwood MR, Sykes RM, et al. Functional and autoradiographic evidence for endothelin 1 receptors on human and rat cardiac myocytes. Comparison with single smooth muscle cells. Circ Res 1990; 67: 764-9.
29. 125I]endothelin binding sites in human blood vessels and coronary tissue: functional correlates. J Cardiovasc Pharmacol 1991; 17: S458-62.
30. Chester AH, Dashwood MR, Clarke JG, et al. Influence of endothelin on human coronary arteries and localisation of its binding sites. Am J Cardiol 1989; 63: 1395-8.
31. Power RF, Wharton J, Zhao Y, Bloom SR, Polak JM. Autoradiographic localization of endothelin-1 binding sites in the cardiovascular and respiratory systems. J Cardiovasc Pharmacol 1989; 13: S50-6.
32. Bloch KD, Eddy RL, Shows TB, Quertermous T. cDNA cloning and chromosomal assignment of the gene encoding endothelin 3. J Biol Chem 1989; 264: 18156-61.
33. Suzuki N, Matsumoto H, Miyauchi T, et al. Endothelin-3 concentrations in human plasma: the increased concentrations in patients undergoing haemodialysis. Biochem Biophys Res Commun 1990; 169: 809-15.
34. Miyauchi T, Suzuki N, Kurihara T, et al. Endothelin-1 and endothelin-3 play different roles in acute and chronic alterations of blood pressure in patients with chronic hemodialysis. Biochem Biophys Res Commun 1991; 178: 276-81.
35. Ando K, Hirata Y, Togashi K, Kawakami M, Marumo F. Endothelin-1- and endothelin-3-like immunoreactivity in human cerebrospinal fluid. J Cardiovasc Pharmacol 1991; 17: S434-6
36. Takahashi K, Ghatei MA, Jones PM, et al. Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J Clin Endocrinol Metab 1991; 72: 693-9.
37. Cameron IT, Plumpton C, Champeney R, van Papendorp C, Ashby MJ, Davenport AP. Identification of endothelin-1, endothelin-2 and endothelin-3 in human endometrium. J Reprod Fertil 1993; 97: 251-5.
38. Yu JCM, Davenport AP. Secretion of endothelin-1 and endothelin-3 fay human cultured vascular smooth muscle cells. Br J Pharmacol 1994; 114: 551-7.
39. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (London) 1988; 332: 411-15.
40. Plumpton C, Kalinka S, Martin RC, Horton JK, Davenport AP. Effects of phosphoramidon and pepstatin A on the secretion of endothelin-1 and big endothelin-1 by human umbilical vein endothelial cells: measurement by two-site enzyme-linked immunosorbent assays. Clin Sci 1994; 87: 245-51.
41. Ashby MJ, Plumpton C, Teale P, Kuc RE, Houghton E, Davenport AP. Analysis of endogenous human endothelin peptides by high performance liquid chromatography and mass spectrometry. J Cardiovasc Pharmacol 26: S247-9.
42. Li K, Stewart DJ, Rouleau J-L. Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles. Circ Res 1991; 69: 301-12.
43. Mebazaa A, Mayoux E, Maeda K, et al. Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am J Physiol 1993; 265: H1841-6.
44. Evans HG, Lewis MJ, Shah AM. Modulation of myocardial relaxation by basal release of endothelin from endocardial endothelium. Cardiovasc Res 1994; 28: 1694-9.
45. Tonnessen T, Naess PA, Kirkenboen KA, Ilebekk A, Christensen G. Alterations in plasma endothelin during passage through the left chambers before and after brief myocardial ischaemia. Cardiovasc Res 1993; 27: 2160-3.